M Lievre

Summary

Country: France

Publications

  1. ncbi request reprint [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials]
    M Lievre
    Service de pharmacologie clinique Faculté de médecine Laennec 69376 Lyon
    Rev Prat 51:1793-9. 2001
  2. pmc Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice
    Denis Pouchain
    Service de Pharmacologie Clinique, Universite Claude Bernard, CNRS UMR 5558, Rue Guillaume Paradin, BP 8071, Lyon Cedex 08, 69376, France
    Trials 14:318. 2013
  3. pmc Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening
    Michel M Lièvre
    Lyon 1 University, F 69003, UMR 5558, Louis Pradel Hospital, Bron F 69677 France
    Trials 12:23. 2011
  4. doi request reprint Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis
    Michel Lievre
    Universite Claude Bernard Lyon 1, UMR5558, Service de Pharmacologie Clinique, Faculte de Medecine, Rue Guillaume Paradin, F 69008 Lyon, France
    Fundam Clin Pharmacol 24:385-91. 2010
  5. doi request reprint Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy
    Michel Lievre
    Department of Pharmacology, Universite Lyon 1, UMR5558, Hospices Civils de Lyon, F 69003 France
    Contraception 80:95-100. 2009
  6. ncbi request reprint Evaluation of adverse treatment effects in controlled trials
    Michel Lievre
    Service de Pharmacologie Clinique, Faculte de Medecine Laennec, Rue Guillaume Paradin, 69008 Lyon, France
    Joint Bone Spine 73:624-6. 2006
  7. ncbi request reprint [Biases in clinical research]
    Michel Lievre
    Service de Pharmacologie Clinique, Hôpitaux de Lyon, EA643, Faculte Laennec, 69376 Lyon Cedex 08
    Rev Prat 53:2096-8. 2003
  8. ncbi request reprint The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group
    M Lievre
    Department of Clinical Pharmacology, Lyon, France
    Control Clin Trials 21:383-96. 2000
  9. ncbi request reprint Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee
    M Lievre
    Clinical Pharmacology Department, Claude Bernard University Equipe d Accueil 643, Lyon Hospitals, France
    Diabetes Care 23:B65-71. 2000
  10. ncbi request reprint Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus
    M Lievre
    Clinical Pharmacology Unit, Lyon Hospitals, Lyon, France
    Diabetes Metab 31:41-6. 2005

Detail Information

Publications13

  1. ncbi request reprint [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials]
    M Lievre
    Service de pharmacologie clinique Faculté de médecine Laennec 69376 Lyon
    Rev Prat 51:1793-9. 2001
    ..The absolute benefit conferred by efficient therapies is higher in diabetic patients because they are at an increased risk of events compared with their non-diabetic counterparts...
  2. pmc Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice
    Denis Pouchain
    Service de Pharmacologie Clinique, Universite Claude Bernard, CNRS UMR 5558, Rue Guillaume Paradin, BP 8071, Lyon Cedex 08, 69376, France
    Trials 14:318. 2013
    ....
  3. pmc Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening
    Michel M Lièvre
    Lyon 1 University, F 69003, UMR 5558, Louis Pradel Hospital, Bron F 69677 France
    Trials 12:23. 2011
    ..We sought to determine whether referring asymptomatic diabetic patients for screening of silent ischemia decreases the risk of cardiovascular events compared with usual care...
  4. doi request reprint Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis
    Michel Lievre
    Universite Claude Bernard Lyon 1, UMR5558, Service de Pharmacologie Clinique, Faculte de Medecine, Rue Guillaume Paradin, F 69008 Lyon, France
    Fundam Clin Pharmacol 24:385-91. 2010
    ..87, 95% CI 1.51-2.32 for all clinical conditions). This meta-analysis confirms that aspirin decreases the risk of thrombotic events in patients with confirmed disease of the coronary, cerebrovascular, or peripheral artery beds...
  5. doi request reprint Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy
    Michel Lievre
    Department of Pharmacology, Universite Lyon 1, UMR5558, Hospices Civils de Lyon, F 69003 France
    Contraception 80:95-100. 2009
    ..There is unsettled controversy about the respective efficacy and safety of 200 and 600 mg mifepristone in combination with two prostaglandins for the termination of pregnancy up to 63 days' gestation...
  6. ncbi request reprint Evaluation of adverse treatment effects in controlled trials
    Michel Lievre
    Service de Pharmacologie Clinique, Faculte de Medecine Laennec, Rue Guillaume Paradin, 69008 Lyon, France
    Joint Bone Spine 73:624-6. 2006
  7. ncbi request reprint [Biases in clinical research]
    Michel Lievre
    Service de Pharmacologie Clinique, Hôpitaux de Lyon, EA643, Faculte Laennec, 69376 Lyon Cedex 08
    Rev Prat 53:2096-8. 2003
  8. ncbi request reprint The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group
    M Lievre
    Department of Clinical Pharmacology, Lyon, France
    Control Clin Trials 21:383-96. 2000
    ..Follow-up is planned to end on March 31, 2001...
  9. ncbi request reprint Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee
    M Lievre
    Clinical Pharmacology Department, Claude Bernard University Equipe d Accueil 643, Lyon Hospitals, France
    Diabetes Care 23:B65-71. 2000
    ..To review the effectiveness of diuretic or beta-blocker-based treatment of hypertension in diabetic patients...
  10. ncbi request reprint Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus
    M Lievre
    Clinical Pharmacology Unit, Lyon Hospitals, Lyon, France
    Diabetes Metab 31:41-6. 2005
    ..To describe the present status of type 1 diabetes care in France and study the relations between clinical and socio-economic variables on one hand and disease management and prevalence of complications on the other hand...
  11. ncbi request reprint [Clinical benefits of cholesterol lowering treatments. Meta-analysis of randomized therapeutic trials]
    M Cucherat
    Service de Pharmacologie Clinique EA 643, Hôpitaux de Lyon, Universite Lyon 1
    Presse Med 29:965-76. 2000
    ..For total mortality, the statin trials were not comparable with other treatments where there was a trend to overmortality. With the 2 statin trials, there was a nonsignificant 13% reduction in total mortality...
  12. ncbi request reprint In vivo measurement of myocardial oxidative metabolism and blood flow does not show changes in cancer patients undergoing doxorubicin therapy
    P Nony
    Department of Clinical Pharmacology, Cardiovascular Hospital, Lyon, France
    Cancer Chemother Pharmacol 45:375-80. 2000
    ....